share_log

以岭药业:以岭药业未来三年(2024-2026年)股东回报规划

Shijiazhuang Yiling Pharmaceutical: Eling Pharmaceutical's shareholder return plan for the next three years (2024-2026)

Sensex a share ·  Apr 26
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more